ANKRD17
Gene Information
- Official Symbol: ANKRD17
- Official Name: ankyrin repeat domain 17
- Aliases and Previous Symbols: N/A
- Entrez ID: 26057
- UniProt: O75179
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| KH 1 |
| Ank 2 |
| Ank |
GO Terms
| positive regulation of MDA-5 signaling pathway |
| regulation of MDA-5 signaling pathway |
| blood vessel maturation |
| positive regulation of RIG-I signaling pathway |
| negative regulation of smooth muscle cell differentiation |
| regulation of RIG-I signaling pathway |
| regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway |
| regulation of smooth muscle cell differentiation |
| positive regulation of G1/S transition of mitotic cell cycle |
| positive regulation of cell cycle G1/S phase transition |
| negative regulation of muscle cell differentiation |
| regulation of defense response to virus |
| positive regulation of mitotic cell cycle phase transition |
| positive regulation of cell cycle phase transition |
| regulation of DNA replication |
| chromatin |
| anatomical structure maturation |
| regulation of G1/S transition of mitotic cell cycle |
| positive regulation of mitotic cell cycle |
| regulation of muscle cell differentiation |
| regulation of cell cycle G1/S phase transition |
| positive regulation of I-kappaB kinase/NF-kappaB signaling |
| positive regulation of immune effector process |
| regulation of I-kappaB kinase/NF-kappaB signaling |
| nuclear membrane |
| developmental maturation |
| positive regulation of cell cycle process |
| defense response to bacterium |
| positive regulation of innate immune response |
| positive regulation of response to biotic stimulus |
| positive regulation of cell cycle |
| chromatin binding |
| regulation of mitotic cell cycle phase transition |
| regulation of cell cycle phase transition |
| positive regulation of cytokine production |
| regulation of innate immune response |
| regulation of immune effector process |
| positive regulation of defense response |
| blood vessel development |
| positive regulation of multi-organism process |
| vasculature development |
| cardiovascular system development |
| regulation of response to biotic stimulus |
| positive regulation of response to external stimulus |
| regulation of mitotic cell cycle |
| response to bacterium |
| regulation of cytokine production |
| viral process |
| negative regulation of cell differentiation |
| regulation of cell cycle process |
| regulation of defense response |
| innate immune response |
| regulation of multi-organism process |
| symbiotic process |
| interspecies interaction between organisms |
| positive regulation of immune response |
| circulatory system development |
| negative regulation of developmental process |
| defense response to other organism |
| positive regulation of intracellular signal transduction |
| regulation of response to external stimulus |
| regulation of immune response |
| positive regulation of immune system process |
| regulation of cell cycle |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| defense response |
| RNA binding |
| regulation of response to stress |
| regulation of immune system process |
| positive regulation of signal transduction |
| positive regulation of multicellular organismal process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| immune response |
| membrane |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| ANKHD1 | 0.414 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 7/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 1/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 1/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 1/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 6095
- Expression level (log2 read counts): 7.77
Expression Distribution
ANKRD17 Expression in NALM6 Cells: 7.77